Literature DB >> 21728913

Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.

Lihua Zhang1, Armen Zakharyan, Karen M Stockl, Ann S M Harada, Bradford S Curtis, Brian K Solow.   

Abstract

OBJECTIVE: To examine medication adherence among Medicare Part D beneficiaries initiating oral anti-diabetic medications and explore whether there is any association of using mail-order pharmacy (vs. retail pharmacy) with better adherence in this patient population. RESEARCH DESIGN AND METHODS: Using administrative pharmacy claims data, we conducted a retrospective cohort study on Medicare Part D beneficiaries who newly initiated oral anti-diabetic treatment between July 1, 2008 and December 31, 2008. Mail-order pharmacy users were matched to retail pharmacy users via propensity scoring, controlling for patient demographic and clinical characteristics. Adherence with oral anti-diabetic medications during the benefit year of 2009 was assessed using the proportion of days covered (PDC). Comparison of medication adherence between the mail-order pharmacy group and retail pharmacy group was conducted in the propensity matched sample using the paired t-tests and McNemar's tests.
RESULTS: A total of 22,546 patients who initiated oral anti-diabetic medications were identified. The average PDC was 0.60 and only 41.6% of the study population attained good adherence (defined as PDC ≥ 0.8) with oral anti-diabetic medications during calendar year 2009. The matched sample included 1361 patients in each of the mail-order and retail pharmacy cohorts. Compared with the retail pharmacy group, mail-order pharmacy users demonstrated a significantly higher PDC (0.68 vs. 0.61; P < 0.001) throughout the benefit year. More patients in the mail-order pharmacy group (49.7%) attained good adherence with their oral anti-diabetic medications compared to 42.8% in the retail pharmacy group (P < 0.001). LIMITATIONS: The study was subject to limitations inherent in retrospective claims database analysis.
CONCLUSIONS: Adherence with oral anti-diabetic medications among Medicare Part D beneficiaries is suboptimal. Patients using mail-order pharmacy had better adherence to oral anti-diabetic medications than those who used retail pharmacies. However, the causal relationship between mail-order pharmacy use and adherence should be further examined in a randomized study setting.

Entities:  

Mesh:

Year:  2011        PMID: 21728913     DOI: 10.3111/13696998.2011.598200

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  13 in total

1.  Relationship Between Medication Adherence and Distance to Dispensing Pharmacies and Prescribers Among an Urban Medicaid Population with Diabetes Mellitus.

Authors:  Samina T Syed; Lisa K Sharp; Yoonsang Kim; Adam Jentleson; Claudia M Lora; Daniel R Touchette; Michael L Berbaum; Katie J Suda; Ben S Gerber
Journal:  Pharmacotherapy       Date:  2016-05-28       Impact factor: 4.705

2.  Impact of a pharmacy benefit change on new use of mail order pharmacy among diabetes patients: the Diabetes Study of Northern California (DISTANCE).

Authors:  Andrew J Karter; Melissa M Parker; O Kenrik Duru; Dean Schillinger; Nancy E Adler; Howard H Moffet; Alyce S Adams; James Chan; Willam H Herman; Julie A Schmittdiel
Journal:  Health Serv Res       Date:  2014-08-15       Impact factor: 3.402

3.  Medicare part D research and policy highlights, 2012: impact and insights.

Authors:  Denys T Lau; JoAnn Stubbings
Journal:  Clin Ther       Date:  2012-03-13       Impact factor: 3.393

4.  Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users.

Authors:  Alyce S Adams; Connie Uratsu; Wendy Dyer; David Magid; Patrick O'Connor; Arne Beck; Melissa Butler; P Michael Ho; Julie A Schmittdiel
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

5.  Safety and effectiveness of mail order pharmacy use in diabetes.

Authors:  Julie A Schmittdiel; Andrew J Karter; Wendy T Dyer; James Chan; O Kenrick Duru
Journal:  Am J Manag Care       Date:  2013-11       Impact factor: 2.229

Review 6.  Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia.

Authors:  Franck Boccara; Ricardo Dent; Luis Ruilope; Paul Valensi
Journal:  Adv Ther       Date:  2017-07-17       Impact factor: 3.845

7.  Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population.

Authors:  Hiep Nguyen; Robert Dufour; Amanda Caldwell-Tarr
Journal:  Adv Ther       Date:  2017-01-11       Impact factor: 3.845

8.  Development, test-retest reliability and validity of the Pharmacy Value-Added Services Questionnaire (PVASQ).

Authors:  Christine L Tan; Mohamed A Hassali; Fahad Saleem; Asrul A Shafie; Hisham Aljadhey; Vincent B Gan
Journal:  Pharm Pract (Granada)       Date:  2015-06-15

9.  Treatment progression in sulfonylurea and dipeptidyl peptidase-4 inhibitor cohorts of type 2 diabetes patients on metformin.

Authors:  Xiaomei Peng; Dingfeng Jiang; Dongju Liu; Oralee J Varnado; Jay P Bae
Journal:  Patient Prefer Adherence       Date:  2016-08-10       Impact factor: 2.711

10.  Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland.

Authors:  Carola A Huber; Oliver Reich
Journal:  Patient Prefer Adherence       Date:  2016-09-15       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.